Cathay Biotech (China) Performance
| 688065 Stock | 42.84 0.22 0.51% |
On a scale of 0 to 100, Cathay Biotech holds a performance score of 8. The firm shows a Beta (market volatility) of -0.31, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Cathay Biotech are expected to decrease at a much lower rate. During the bear market, Cathay Biotech is likely to outperform the market. Please check Cathay Biotech's total risk alpha, treynor ratio, and the relationship between the jensen alpha and sortino ratio , to make a quick decision on whether Cathay Biotech's price patterns will revert.
Risk-Adjusted Performance
8 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Cathay Biotech are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Cathay Biotech sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Forward Dividend Yield 0.0044 | Payout Ratio 0.2794 | Last Split Factor 1.4:1 | Forward Dividend Rate 0.19 | Ex Dividend Date 2024-07-24 |
1 | What Cathay Biotech Inc.s 38 percent Share Price Gain Is Not Telling You - Simply Wall St | 10/22/2024 |
2 | Cathay General Bancorp Shares Purchased by Dean Investment Associates LLC - MarketBeat | 12/09/2024 |
| Begin Period Cash Flow | 6.2 B |
Cathay |
Cathay Biotech Relative Risk vs. Return Landscape
If you would invest 3,396 in Cathay Biotech on September 19, 2024 and sell it today you would earn a total of 910.00 from holding Cathay Biotech or generate 26.8% return on investment over 90 days. Cathay Biotech is generating 0.4786% of daily returns and assumes 4.1938% volatility on return distribution over the 90 days horizon. Simply put, 37% of stocks are less volatile than Cathay, and 91% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Cathay Biotech Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cathay Biotech's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Cathay Biotech, and traders can use it to determine the average amount a Cathay Biotech's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1141
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | 688065 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.19 actual daily | 37 63% of assets are more volatile |
Expected Return
| 0.48 actual daily | 9 91% of assets have higher returns |
Risk-Adjusted Return
| 0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average Cathay Biotech is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cathay Biotech by adding it to a well-diversified portfolio.
Cathay Biotech Fundamentals Growth
Cathay Stock prices reflect investors' perceptions of the future prospects and financial health of Cathay Biotech, and Cathay Biotech fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cathay Stock performance.
| Return On Equity | 0.026 | ||||
| Return On Asset | 0.0106 | ||||
| Profit Margin | 0.14 % | ||||
| Operating Margin | 0.20 % | ||||
| Current Valuation | 21.78 B | ||||
| Shares Outstanding | 583.38 M | ||||
| Price To Book | 2.21 X | ||||
| Price To Sales | 9.04 X | ||||
| Revenue | 2.11 B | ||||
| Gross Profit | 2.44 B | ||||
| EBITDA | 608.83 M | ||||
| Net Income | 366.52 M | ||||
| Total Debt | 1.53 B | ||||
| Book Value Per Share | 19.74 X | ||||
| Cash Flow From Operations | 569.45 M | ||||
| Earnings Per Share | 0.68 X | ||||
| Total Asset | 18.83 B | ||||
| Retained Earnings | 2.07 B | ||||
About Cathay Biotech Performance
By analyzing Cathay Biotech's fundamental ratios, stakeholders can gain valuable insights into Cathay Biotech's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Cathay Biotech has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Cathay Biotech has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Cathay Biotech is entity of China. It is traded as Stock on SHG exchange.Things to note about Cathay Biotech performance evaluation
Checking the ongoing alerts about Cathay Biotech for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Cathay Biotech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Cathay Biotech had very high historical volatility over the last 90 days | |
| Cathay Biotech is unlikely to experience financial distress in the next 2 years | |
| About 61.0% of the company shares are owned by insiders or employees | |
| Latest headline from news.google.com: Cathay General Bancorp Shares Purchased by Dean Investment Associates LLC - MarketBeat |
- Analyzing Cathay Biotech's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cathay Biotech's stock is overvalued or undervalued compared to its peers.
- Examining Cathay Biotech's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Cathay Biotech's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cathay Biotech's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Cathay Biotech's stock. These opinions can provide insight into Cathay Biotech's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Cathay Stock analysis
When running Cathay Biotech's price analysis, check to measure Cathay Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cathay Biotech is operating at the current time. Most of Cathay Biotech's value examination focuses on studying past and present price action to predict the probability of Cathay Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cathay Biotech's price. Additionally, you may evaluate how the addition of Cathay Biotech to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Stocks Directory Find actively traded stocks across global markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Transaction History View history of all your transactions and understand their impact on performance |